Roger W. Jelliffe
- Pharmacology top 0.2%
- Infectious Diseases top 1%
- Epidemiology top 2%
- Pediatrics, Perinatology and Child Health top 1%
- Oncology top 5%
- Co-authors
- Michael NeelyAlan SchumitzkyPascal MaireWalter M. YamadaMichael Van GuilderDavid S. BayardGary BrookerM. Van Guilder
- Topics
- Antibiotics Pharmacokinetics and Efficacy (56 papers)Pharmacogenetics and Drug Metabolism (22 papers)Statistical Methods in Clinical Trials (22 papers)
- Partner nations
- United StatesFranceNetherlands
In The Last Decade
Roger W. Jelliffe
143 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 147
- Pharmacology 2.1k
- Infectious Diseases 1.2k
- Epidemiology 1.2k
- Pediatrics, Perinatology and Child Health 745
- Oncology 507
Countries citing papers authored by Roger W. Jelliffe
This map shows the geographic impact of Roger W. Jelliffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger W. Jelliffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger W. Jelliffe more than expected).
Fields of papers citing papers by Roger W. Jelliffe
This network shows the impact of papers produced by Roger W. Jelliffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger W. Jelliffe. The network helps show where Roger W. Jelliffe may publish in the future.
Co-authorship network of co-authors of Roger W. Jelliffe
This figure shows the co-authorship network connecting the top 25 collaborators of Roger W. Jelliffe. A scholar is included among the top collaborators of Roger W. Jelliffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger W. Jelliffe. Roger W. Jelliffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 13 | |
| 7 | 2 | |
| 8 | 15 | |
| 9 | 3 | |
| 10 | Pharmacokinetics of ethambutol in children and adults with tuberculosis. | 62 |
| 11 | 39 | |
| 12 | 101 | |
| 13 | 15 | |
| 14 | 9 | |
| 15 | 26 | |
| 16 | 23 | |
| 17 | 43 | |
| 18 | 13 | |
| 19 | A Time-Shared Computer Program for Adaptive Control of Lidocaine Therapy Using an Optimal Strategy for Obtaining Serum Concentrations. | 2 |
| 20 | A Package of Time-Shared Computer Programs for Patient Care | 1 |
About Roger W. Jelliffe
Roger W. Jelliffe is a scholar working on Pharmacology, Statistics and Probability and Pharmacology, having authored 148 papers that have together received 5.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (56 papers), Pharmacogenetics and Drug Metabolism (22 papers) and Statistical Methods in Clinical Trials (22 papers). The work is most often cited by research in Pharmacology (2.1k citations), Transplantation (279 citations) and Molecular Medicine (495 citations). Roger W. Jelliffe has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Michael Neely, Alan Schumitzky, Pascal Maire, Walter M. Yamada, Michael Van Guilder, David S. Bayard, Gary Brooker, M. Van Guilder, Paul M. Beringer and Charles A. Peloquin. Their work appears in journals such as JAMA, Circulation and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.